Health Policy and Management (보건행정학회지)

Korean Academy of Health Policy and Management (한국보건행정학회)
권호 표지
DOI QR코드

DOI QR Code

The Effects of Adherence and Hypertension Control on Complication among Newly Diagnosed Hypertension Patients

신규 고혈압 환자의 치료지속성과 고혈압 조절 여부가 심뇌혈관질환 합병증에 미치는 영향

  • Han, Jin-Ok (Graduate School of Medicine, Gachon University) ;
  • Yim, Jun (Graduate School of Medicine, Gachon University) ;
  • Im, Jeong-Soo (Graduate School of Medicine, Gachon University) ;
  • Lee, Hee Young (Public Health Institute, Seoul National University Bundang Hospital) ;
  • Park, Jong Heon (Big Data Steering Department, National Health Insurance Service) ;
  • Oh, Dae-kyu (Graduate School of Medicine, Gachon University)
  • 한진옥 (가천대학교 의학전문대학원) ;
  • 임준 (가천대학교 의학전문대학원) ;
  • 임정수 (가천대학교 의학전문대학원) ;
  • 이희영 (분당서울대병원 공공의료사업단) ;
  • 박종헌 (국민건강보험공단 빅데이터운영실) ;
  • 오대규 (가천대학교 의학전문대학원)
  • Received : 2015.03.30
  • Accepted : 2015.06.26
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This study aimed to research on how adherence and blood control could make a difference when it comes to develop complications. Methods: The study's subjects were 255,916 patients who were newly diagnosed with hypertension in 2009 using data collected by National Health Insurance Cooperation. Patients are considered as a group under adherence if visit days and prescription days are more than 300 days. Patients are considered to have successfully controled their hypertension based on actual value measured by National Health Insurance Cooperation and the study takes a look at whether they were diagnosed with complications of cerebrocardiovascular disease in 2012. Chi-square test and logistic regression was used to analyze. Results: Patients who were able to control their hypertension show 0.80 times chance of developing cerebrovascular disease, and 0.89 times chance of developing cardiocerebrovascular disease. The group of adherence shows lower chance of developing complication in general than the group of non-adherence. Conclusion: The study revealed that hypertension's constant treatment could control the blood pressure and prevent complications. It is important that encourages patients to effort for persistent treatment for reducing complication.

Keywords

References

  1. Statistics Korea. [Internet]. Daejeon: Statistics Korea; 2011 [cited 2015 May 20]. Available from: https://www.index.go.kr/egams/stts/jsp/potal/stts/PO_STTS_IdxMain.jsp?idx_cd=1010&bbs=INDX_001.
  2. The Korean Society of Hypertension. 2004 Korean hypertension treatment guidelines. Seoul: The Korean Society of Hypertension; 2004.
  3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360(9349):1903-1913. DOI: http://dx.doi.org/10.1016/s0140-6736(02)11911-8.
  4. Statistics Korea. [Internet]. Daejeon: Statistics Korea; 2012 [cited 2015 May 20]. Available from: https://www.index.go.kr/egams/stts/jsp/potal/stts/PO_STTS_IdxMain.jsp?idx_cd=1012&bbs=INDX_001.
  5. World Health Organization. Prevention of cardiovascular disease: guideline for assessment and management of cardiovascular risk. Geneva: World Health Organization; 2007.
  6. Centers for Disease Control and Prevention. 2013 Korean National Health and Nutritional Examination Survey. Cheongju: Centers for Disease Control and Prevention; 2013.
  7. Yoon SS, Burt V, Louis T, Carroll MD. Hypertension among adults in the United States, 2009-2010. NCHS Data Brief 2012;(107):1-8.
  8. Cho WS. The related of continuity of hospitalization and the medication adherence and health result for new patient with hypertension [dissertation]. Seoul: Korea University; 2011.
  9. Park JH. Antihypertensive drug medication adherence of national health insurance beneficiaries and its affecting factors in Korea [dissertation]. Seoul: Seoul National University; 2006.
  10. Seo YM. Factors influencing medication adherence in hypertensive patients. J Korean Acad Community Health Nurs 2010;21(1):82-91. DOI: http://dx.doi.org/10.12799/jkachn.2010.21.1.82.
  11. Son KA. Factors affecting continuity of taking drugs and therapy of hypertension patients in Korea [dissertation]. Seoul: Hanyang University; 2010.
  12. Min ES, Hur MH. Predictors of compliance in hypertensive patients. J Korean Acad Fundam Nurs 2012;19(4):474-482. https://doi.org/10.7739/jkafn.2012.19.4.474
  13. Han JO, Oh DK, Yim J, Ko KP, Lee HY, Park JH, et al. The effects of adherence on hypertension control among newly diagnosed hypertension patients. Health Policy Manag 2014;24(2):136-142. DOI: http://dx.doi.org/10.4332/kjhpa.2014.24.2.136.
  14. The Korean Society of Hypertension. 2013 Korean hypertension treatment guidelines. Seoul: The Korean Society of Hypertension; 2013.
  15. Korea Institute for Health and Social Affairs. Statistics dictionary. Sejong: Korea Institute for Health and Social Affairs.
  16. Sung SK. Medication adherence and the treatment-related factors in the patients initiating antihypertensive therapy [dissertation]. Daejeon: Chungnam National University; 2008.
  17. Cheong W. The factors affecting adherence and blood pressure or glycemic control in patients with hypertension and type 2 diabetes mellitus before and after patient incentive program in Incheon [dissertation]. Incheon: Gachon University; 2013.
  18. Health Insurance Review and Assessment Service. Analysis of health care costs and health outcomes according to treatment persistence: hypertension, diabetes. Seoul: Health Insurance Review and Assessment Service; 2010.
  19. Lim BD, Chun BY, Kam S, Im JS, Park SW, Park JH. Annual visit days, prescription days and medical expenses of hypertensive patients. Korean J Prev Med 2002;35(4):340-350.
  20. Kim HJ. The economic burden of stroke and continuity of care, medical costs & health outcomes of hypertension [dissertation]. Seoul: Korea University; 2013.
  21. Vlasnik JJ, Aliotta SL, DeLor B. Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager 2005; 16(2):47-51. DOI: http://dx.doi.org/10.1016/j.casemgr.2005.01.009.
  22. Yeo JY, Jeong HS. Determinants of health screening and its effects on health behaviors. Health Policy Manag 2012;22(1):49-64. DOI: http://dx.doi.org/10.4332/kjhpa.2012.22.1.049.
  23. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009;25(9):2303-2310. DOI: http://dx.doi.org/10.1185/03007990903126833.
  24. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120(16):1598-1605. DOI: dx.doi.org/10.1161/CIRCULATIONAHA. 108.830299.
  25. Kettani FZ, Dragomir A, Cote R, Roy L, Berard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009;40(1):213-220. DOI: http://dx.doi.org/10.1161/STROKEAHA.108.522193.
  26. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess 2003;7(31):1-94. DOI: http://dx.doi.org/10.3310/hta7310.
  27. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275(20):1571-1576. DOI: http://dx.doi.org/10.1001/jama.1996.03530440051036.
  28. National Health Insurance Corporation. 2009 National health screening statistical yearbook. Seoul: National Health Insurance Corporation; 2009.
  29. The Korean Society of Hypertension. 2007 Korean hypertension treatment guidelines. Seoul: The Korean Society of Hypertension; 2007.